D
Axsome Therapeutics, Inc. AXSM
$121.91 $0.260.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 24.06% -3.86% -18.13% -509.35% -61.09%
Total Depreciation and Amortization 19.14% 18.24% 18.00% 10.17% 2.84%
Total Amortization of Deferred Charges 55.95% 7.18% -29.48% 5.99% 31.21%
Total Other Non-Cash Items -47.14% 150.68% 5.65% 50.63% 319.42%
Change in Net Operating Assets 273.69% 156.09% 272.97% 29.29% -79.49%
Cash from Operations 13.70% 65.21% 45.60% -818.52% -10.15%
Capital Expenditure -328.57% 75.74% 60.90% -38.03% 96.13%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -328.57% 75.74% 60.90% -38.03% 96.13%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1,434.24% -12.28% -92.22% 546.25% -59.53%
Repurchase of Common Stock -90.36% -33.24% -298.80% -86.62% -71.78%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -183.74% 49.29% 86.06% 35.47% 45.81%
Cash from Financing 712,300.00% -8.89% -94.16% -102.30% -100.19%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 60.53% 156.86% -108.28% -219.88% -13.84%
Weiss Ratings